This text is a result of machine translation.
Zhihu response was added to the "pre delisting" list: the follow-up will pay close attention to the progress, and the impact of this event on Zhihu is limited
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Guangdong hydropower: terminate the public offering of convertible bonds and withdraw the application documents
Brazil's Semiconductors Get Boost: Incentives to Draw 30Bn Reais in a Decade
Sep 14, 2024 05:44 PM
New media index list of Chinese enterprises in November: China Telecom ranked first, China Mobile and PetroChina ranked second and third
Know how to be included in the FTSE index
Zhihu publishes very good growth figures
The Influence of Leadership Change in Latin American Countries on Chinese Enterprises(One)
Sep 04, 2024 09:50 PM
Chinese Companies Going Overseas: Blindly Copying Foreign Companies is “Seeking Death”
Sep 04, 2024 08:37 PM